 | Up a level |
Abdulsamad, Saud A, Naeem, Abdulghani A, Zeng, Hao, He, Gang, Jin, Xi, Alenezi, Bandar A, Ai, Jianzhong, Zhang, Jiacheng, Ma, Hongwen, Rudland, Philip S 
ORCID: 0000-0002-7491-0846 et al (show 1 more authors)
(2024)
Experimental treatment efficacy of dmrFABP5 on prostate cancer singly or in combination with drugs in use.
American journal of cancer research, 14 (1).
pp. 300-323.
Naeem, Abdulghani A, Abdulsamad, Saud A, Zeng, Hao, He, Gang, Jin, Xi, Zhang, Jiacheng, Alenezi, Bandar T, Ma, Hongwen, Rudland, Philip S ORCID: 0000-0002-7491-0846 and Ke, Youqiang ORCID: 0000-0001-5341-8644
(2024)
FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells.
International journal of oncology, 64 (2).
18-.
He, Wenhua, Chen, Peng, Lei, Yupeng, Xia, Liang, Liu, Pi, Zhu, Yong, Zeng, Hao, Wu, Yao, Ke, Huajing, Huang, Xin et al (show 6 more authors)
(2022)
Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis.
CRITICAL CARE, 26 (1).
52-.